The PE Ratio as of November 2024 (TTM) for Morphic Holding, Inc. (MORF) is -14.88

According to Morphic Holding, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -14.88. This represents a change of 81.37% compared to the average of -8.20 of the last 4 quarters.

Morphic Holding, Inc. (MORF) Historical PE Ratio (quarterly & annually)

How has MORF PE Ratio performed in the past?

The mean historical PE Ratio of Morphic Holding, Inc. over the last ten years is -17.10. The current -14.88 PE Ratio has changed 8.60% with respect to the historical average. Over the past ten years (40 quarters), MORF's PE Ratio was at its highest in in the September 2020 quarter at 38.98. The PE Ratio was at its lowest in in the March 2021 quarter at -24.92.

Morphic Holding, Inc. (MORF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Morphic Holding, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Morphic Holding, Inc. (MORF) Average PE Ratio

How has MORF PE Ratio performed in the past?

The current PE Ratio of Morphic Holding, Inc. (MORF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Morphic Holding, Inc. (MORF) PE Ratio vs. Peers

How is MORF’s PE Ratio compared to its peers?

Morphic Holding, Inc.’s PE Ratio is greater than Arcellx, Inc. (-85.84), less than Ventyx Biosciences, Inc. (-0.89), greater than Immunocore Holdings plc (-25.92), greater than Vaxcyte, Inc. (-25.11), greater than DICE Therapeutics, Inc. (-23.17), less than 89bio, Inc. (0), less than Madrigal Pharmaceuticals, Inc. (-5.31), less than Pliant Therapeutics, Inc. (-13.89), less than Stoke Therapeutics, Inc. (-4.72), less than Akero Therapeutics, Inc. (-7.05), less than Terns Pharmaceuticals, Inc. (-10.86), less than Inozyme Pharma, Inc. (-5.51), less than Viking Therapeutics, Inc. (-3.09), greater than Revolution Medicines, Inc. (-70.63), greater than Avidity Biosciences, Inc. (-17.77), greater than Protagonist Therapeutics, Inc. (-18.98), less than null (16.87),

Build a custom stock screener for Morphic Holding, Inc. (MORF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Morphic Holding, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Morphic Holding, Inc. (MORF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Morphic Holding, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.